ABSTRACT: Particle Therapy (PT) is an emerging technique, which makes use of charged particles to efficiently cure different kinds of solid tumors. The high precision in the hadrons dose deposition requires an accurate monitoring to prevent the risk of under-dosage of the cancer region or of overdosage of healthy tissues. Monitoring techniques are currently being developed and are based on the detection of particles produced by the beam interaction into the target, in particular: charged particles, result of target and/or projectile fragmentation, prompt photons coming from nucleus deexcitation and back-to-back γs, produced in the positron annihilation from β + emitters created in the beam interaction with the target. It has been showed that the hadron beam dose release peak can be spatially correlated with the emission pattern of these secondary particles. Here we report about secondary particles production (charged fragments and prompt γs) performed at different beam and energies that have a particular relevance for PT applications: 12 C beam of 80 MeV/u at LNS, 12 C beam 220 MeV/u at GSI, and 12 C, 4 He, 16 O beams with energy in the 50-300 MeV/u range at HIT. Finally, a project for a multimodal dose-monitor device exploiting the prompt photons and charged particles emission will be presented.
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Introduction
PT is an emerging technique ( [1] [2] [3] [4] [5] ) alternative to conventional radiotherapy (RT), which makes use of charged particles, usually protons and carbon ions, to treat different kinds of solid tumors. Charged particles most attractive feature with respect to the X-rays exploited in RT treatments is their dose profile, showing the highest dose release at the end of their path inside the patient's body, in a region called Bragg Peak (BP). On the other hand the dose released in the entrance region is reduced with respect to the RT, helping to spare the healthy tissues crossed by the beam before the tumor region and, moreover, it is highly suppressed in the region just beyond the BP. The track length is a function of the beam energy, and by using beams of different energies it is possible to accurately conform the dose to the tumor shape (Spread Out Bragg Peak). Moreover carbon ions are characterized by higher LET values with respect to X-rays and thus are more efficient in killing radio-resistant tumours, with a higher Relative Biological Effectiveness (RBE). Due to the ballistic precision of PT, the treatment is extremely sensitive to anatomical changes and patient mis-positioning, with related risk of under-dosage of the cancer region or over-dosage of the healthy tissues. The stringent requirements on the PT dose deposition position control are calling for the development of a high precision on line monitor. Unfortunately, unlike X-rays in conventional RT, the hadron beam is completely absorbed by the body, which implies that it is not possible to use the fraction of the beam escaping from the patient. A promising way to overcome this limitation is to detect secondary particles produced by the beam interaction with patient tissues: charged particles, originating from the projectile and target fragmentation, prompt gammas from nucleus de-excitation, with emission times up to few nanoseconds and pairs of backto-back photons produced by the annihilation of positrons coming from β + emitters generated by the beam interaction with the patient. The dose release peak can be correlated with the emission pattern of these secondary particles ( [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . Here we present a summary of such measurements, together with the design of a multimodal dose-monitor to be operated at the Centro Nazionale per l'Adroterapia Oncologica (CNAO) in Pavia (Italy). The monitor system will be composed of a two PET heads module, for an online monitoring of the β + emitters production, and of a dose profiler that will be able to detect, track and measure the energy of both secondary charged particles and prompt gammas, with a spatial resolution of nearly 4 mm for a single pencil beam. -2 -
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The measured differential production rate, above 2 MeV, per number of carbon ions, N c and solid angle, Ω, has been evaluated as:
Evidence of prompt gammas detected at 60 • and 90 • has been found also with 4 He and 16 O beams at HIT facility. Data from these measurements have still to be analysed and the results showed below are just preliminary. Figure 2 shows raw charge-to-digital converted (QDC) counts as a function of ∆T distribution, for a 125 MeV/u 4 He beam. 
Charged particles
To measure the charged particles component emitted by the LNS 80 MeV/u 12 C beam, the setup previously described was integrated with a drift chamber (DC) between the PMMA target and the LYSO detector, to track ions from the detector back to the production region inside the target.
The charged particles emitted at 90 • with respect to the beam incoming direction have a flux that is highly reduced when compared to the forward production (around 0 • ) but, on the other side, they have to travel a smaller path inside the PMMA phantom and hence suffer for a reduced multiple scattering. The improvement in the spatial resolution achievable on the emission point pairs with the need, from the MC community, to have a good experimental description of the large angle emission of charged fragments that is currently poorly reproduced by the simulations are the reason why a 90 • geometrical setup has been used to study the charged particles production in the -3 -different experimental sites. Figure 3 (left) shows, the experimental distribution of the emission points of protons inside the PMMA, obtained for all charged particles identified as protons and for protons with different kinetic energy (E kin > 60 MeV and E kin > 100 MeV). The separation between the BP and the peak from the secondary protons emission has been evaluated as ∆ ProtonBragg = 8.1 mm ± 0.5 mm: such measurement proves the BP monitoring capability of a charged particles based monitoring technique. To demonstrate the linear relationship between the x-position of the BP and the mean x-position value of the distribution of secondary particles emission point, a linear position scan of the PMMA target along the beam direction was done. Figure 3 (right) shows how the peak x-coordinate of the charged emission follows the movement of the target, and hence of the BP position, along the beam direction (x PMMA coordinate). Since y PMMA is the coordinate of the proton emission point along the vertical axis, and it is related to the fixed beam profile in the transverse plane, it remains constant with respect to the BP abscissa, x Bragg , and it provides an estimate of the method's systematic uncertainty. The backtracking of the charged secondary particles allows measuring the BP position with a resolution σ Emission of ≈ 0.7 mm, evaluated as:
where: σ Extrapol = 0.5 mm is due to the backward extrapolation of the track from the drift chamber to the beam line (and can be evaluated as σ yPMMA ), σ ∆ProtonBragg ≈ 0.9 mm is the root mean square of ∆ ProtonBragg and σ Stage = 0.2 mm is the uncertainty on the PMMA positioning. The flux of the secondary protons measured at 90 • with respect to the beam direction with kinetic energy E kin > 83 MeV (kinetic energy threshold for a proton capable of escaping a 5 cm deep tumor accordingly to the FLUKA ( [16, 17] ) MC simulation software), normalized to the number of incoming carbon ions, N C , and detector solid angle, Ω, is: Measured fluxes, normalized to the number of incoming carbon ions, N C , and detector solid angle, Ω, are:
The charged secondary fragments spatial distribution ( figure 5 (a) ) is clearly linked to the BP position and it is hence possible to correlate the parameters of an analytical function that describes the measured spectrum to its position, as shown in figure5 (b). The ∆ 40 parameter represents the width of the distribution at 40% of its maximum, X left and X right are the values at rising and falling edges, respectively, and δ 40 is the distance between X left and the x-intercept of the tangent to the distribution at X = X right . X left can be related to the position of the patient during a treatment that is crucial information for dose monitoring. The parameters measured resolutions are listed in figure 5 (c) , and are relative to a sample of 10 3 charged secondary particles corresponding approximately to one pencil beam for a standard treatment. The accuracy achievable on the position of one tumor slice treated with a number N Beams of pencil beams will, hence, be sub millimetric.
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Multimodal dose monitor
The INSIDE (Innovative Solutions for In-beam Dosimetry in hadrontherapy) project is born from the collaboration of a number of Italian Universities (Pisa, Rome, Turin, and Politecnico di Bari) and INFN to build a multimodal in-beam dose monitor that will be able to detect at the same time, back-to-back gammas from β + annihilation (not covered in this contribution), charged secondary particles emerging from the patient and prompt gammas with energies higher than 1 MeV. The monitor layout foresees of a couple of 10 × 20 cm 2 PET heads for back-to-back gammas detection and a 20 × 20 cm 2 dual-mode dose profiler made of 3 sub-detectors: a tracker, an absorber and a calorimeter. The profiler aim is the simultaneous detection and back-tracking of charged particles and prompt gammas (reconstructing the Compton scattering). Figure 7 shows the two working principles for charge and neutral particles detection. The tracker will be made of 6 XY planes of 384 (0.5 × 0.5 mm 2 ) BCF-12 plastic scintillating fibers, read out by S12571-050 Hamamatsu 1 mm 2 SiPM coupled to a 32 channel custom ASIC BA-SIC32 ADC. Behind the tracker, a 2.4 cm thick EJ-200 plastic scintillator slab will be positioned to absorb and measure the energy of Compton electrons. Finally a calorimeter, made of 4 × 4 matrices of scintillating pixelated LYSO crystals, will detect and measure the energy of Compton gammas and charged particles. Each matrix is made of a 16 × 16 array of 2 cm thick LYSO that are read by a multianode H8500 PMT. The profiler geometrical layout and the corresponding hardware technology have been optimized using a full FLUKA MC simulation of a PT treatment in which the secondary particles measurements presented in this contribution were implemented. The multimodal dose monitor is nowadays under construction and will be tested at CNAO center.
Discussion and conclusion
Quality control in PT treatments needs new devices for on-line dose monitoring. We presented here a multi-modal device, composed of two PET heads and a dose profiler thought to operate simultaneously as a charged particle tracker and to reconstruct Compton events from prompt gammas. To develop this device we performed a set of measurements of yields, emission points distribution and energy spectrum of the secondary charged and neutral particles produced by the therapeutic beam interacting with a PMMA phantom. The geometrical and physical detector parameters have been optimized by an accurate MC simulation based on such measurements results. The achievable -7 -spatial resolution to localize the BP position, related to the charged particle spatial resolution has been evaluated less than 4 mm for one pencil beam. Aiming at the detection of the position of a tumor slice treated with a number N Beams of pencil beams, this result must by divided by √ N Beams , thus achieving the sub-millimeter range.
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